← All trials
NCT03275350
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 5, 2018
- Primary completion
- Mar 6, 2020
- Completion date
- Mar 6, 2020
- First posted
- —
- Last posted
- —
- Enrollment
- 350
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Oregon Health and Science UniversityLead sponsor
- National Institute on Drug Abuse (NIDA)Collaborator
- Johns Hopkins UniversityCollaborator
- Oregon Health and Science UniversityReponsible party - principal investigator
- Ruth M. Rothstein CORE CenterCollaborator
- University of KentuckyCollaborator
- University of MiamiCollaborator
- Tarzana Treatment CentersCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.